tesevatinib
Showing 1 - 2 of 2
Polycystic Kidney, Autosomal Dominant Trial in United States (KD019 (tesevatinib))
Completed
- Polycystic Kidney, Autosomal Dominant
- Tesevatinib
-
Los Angeles, California
- +10 more
Oct 12, 2022
NSCLC, Leptomeningeal Metastases, Brain Metastases Trial in United States (Tesevatinib)
Completed
- Non-Small Cell Lung Cancer
- +2 more
- Tesevatinib
-
Beverly Hills, California
- +6 more
Mar 7, 2022